scholarly journals Mycobacterial Brain Tuberculomas due to Bacille Calmette-Guérin Intravesical Chemotherapy for Bladder Cancer: A Case Report and Literature Review

2011 ◽  
Vol 22 (3) ◽  
pp. 104-106 ◽  
Author(s):  
Vitaly Golub ◽  
Prashant Malhotra ◽  
Shital Patel
Keyword(s):  
Central Nervous System ◽  
Bladder Cancer ◽  
Nervous System ◽  
Superficial Bladder Cancer ◽  
Present Report ◽  
Bacille Calmette Guerin ◽  
Bcg Immunotherapy ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

Bacille Calmette-Guérin (BCG) immunotherapy is widely used for the treatment of superficial bladder cancer. The authors believe that the present report is one of the first to document cerebral BCG tuberculoma in a 73-year-old immunocompetent man, three years after intra-vesical BCG immunotherapy. His workup revealed no identifiable extracranial source. He responded well to treatment with rifampin, ethambutol and moxifloxacin.Patients undergoing intravesical BCG therapy should be closely monitored for the development of this complication. Prolonged antitubercular therapy, possibly including moxifloxacin, appears to be beneficial in the treatment of central nervous system tuberculous infections.

scholarly journals Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer

2012 ◽  
Vol 1 (3) ◽  
Author(s):  
Vincent Fradet ◽  
Christiane Gaudreau ◽  
Paul Perrotte ◽  
Jean Côté ◽  
Jean-Marie Paquin
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Mycobacterium Bovis ◽  
Superficial Bladder Cancer ◽  
Granulomatous Hepatitis ◽  
Bacille Calmette Guerin ◽  
Systemic Complications ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Management Alternatives

Intravesical bacille Calmette-Guérin (BCG) therapy is the most effective treatmentfor high-risk superficial bladder cancer. Severe systemic complications are rare, but may occur in approximately 1% of cases. We report a severe complicationof intravesical BCG: a disseminated Mycobacterium bovis infectionwith biopsy-proven granulomatous hepatitis in a patient with bladder cancer. We also elaborate on the different management alternatives.

Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer

1998 ◽  
Vol 30 (1) ◽  
pp. 41-44 ◽  
Author(s):  
F. Yalçinkaya ◽  
L. Kamiş ◽  
O. Özteke ◽  
B. Günlüsoy ◽  
O. Yiĝitbasi ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Standard Dose ◽  
Low Doses ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

UP-01.059 Evaluation of the Need for Transuretheral Biopsy at First Follow-Up After Intravesical BCG Therapy for Superficial Bladder Cancer

Urology ◽  
2011 ◽  
Vol 78 (3) ◽  
pp. S203
Author(s):  
K. Hammoud ◽  
M. Elsheikh ◽  
H. Abdelraouf ◽  
A. Aboumohamed ◽  
Y. Ramadan ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

Intravesical BCG-Therapy for Superficial Bladder Cancer: Its Effectiveness and Adverse Effects

1996 ◽  
Vol 27 (S 1) ◽  
pp. 51-53
Author(s):  
H. Tanaka ◽  
J. Yoshimasa ◽  
Y. Furukawa ◽  
Y. Arai ◽  
T. Araki
Keyword(s):  
Bladder Cancer ◽  
Adverse Effects ◽  
Superficial Bladder Cancer ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

scholarly journals Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer

1997 ◽  
Vol 25 (1) ◽  
pp. 31-34 ◽  
Author(s):  
E. C. de Boer ◽  
L. Somogyi ◽  
G. J. W. de Ruiter ◽  
Th. M. de Reijke ◽  
K. -H. Kurth ◽  
...  
Keyword(s):  
Immune Response ◽  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Interleukin 8 ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer

1994 ◽  
Vol 22 (3) ◽  
pp. 177-184 ◽  
Author(s):  
M. J. J. G. Stassar ◽  
P. D. J. Vegt ◽  
P. A. Steerenberg ◽  
A. P. M. van der Meijden ◽  
H. D. Meiring ◽  
...  
Keyword(s):  
Immune Response ◽  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Local Immune Response ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

Role of Fibronectin in Intravesical BCG Therapy for Superficial Bladder Cancer

1988 ◽  
Vol 139 (2) ◽  
pp. 410-414 ◽  
Author(s):  
Timothy L. Ratliff ◽  
Louis R. Kavoussi ◽  
William J. Catalona
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy

Clinical value of pathologic changes after intravesical BCG therapy of superficial bladder cancer

Urology ◽  
1992 ◽  
Vol 40 (2) ◽  
pp. 175-179 ◽  
Author(s):  
Pierfrancesco Bassi ◽  
Claudio Milani ◽  
Agostino Meneghini ◽  
Antonio Garbeglio ◽  
Francesco Aragona ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Clinical Value ◽  
Bcg Therapy ◽  
Intravesical Bcg ◽  
Intravesical Bcg Therapy
Sign in / Sign up

Export Citation Format

Share Document